Development of CXCR3 antagonists. Part 2: Identification of 2-amino(4-piperidinyl)azoles as potent CXCR3 antagonists

This publication has 14 references indexed in Scilit:

• Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3
  Bioorganic & Medicinal Chemistry Letters, 2007
• Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease
  Trends in Pharmacological Sciences, 2006
• Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Synthesis and structure–activity relationship of 3-phenyl-3H-quinazolin-4-one derivatives as CXCR3 chemokine receptor antagonists
  Bioorganic & Medicinal Chemistry Letters, 2005
• CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets
  Current Drug Target - Immune, Endocrine & Metabolic Disorders, 2005
• Inhibition of IFN-γ-Inducible Protein-10 Abrogates Colitis in IL-10−/− Mice
  The Journal of Immunology, 2003
• Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients
  Surgery, 2003
• Targeting the Function of IFN-γ-Inducible Protein 10 Suppresses Ongoing Adjuvant Arthritis
  The Journal of Immunology, 2002
• Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection
  Journal of Experimental Medicine, 2000
• A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
  Proceedings of the National Academy of Sciences, 1999